James Lind Care Aps

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.2% 1.8% 3.1% 0.9% 3.9%  
Credit score (0-100)  44 71 55 88 49  
Credit rating  BBB A BBB A BBB  
Credit limit (kDKK)  0.0 0.8 0.0 636.9 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,268 1,949 3,266 12,175 10,192  
EBITDA  16.5 816 102 5,048 -628  
EBIT  16.5 816 -13.2 4,624 -2,069  
Pre-tax profit (PTP)  15.8 814.8 -22.5 4,532.2 -2,555.4  
Net earnings  12.2 635.2 609.9 3,524.7 -2,002.4  
Pre-tax profit without non-rec. items  15.8 815 -22.5 4,532 -2,555  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  785 1,420 1,018 4,542 2,540  
Interest-bearing liabilities  0.0 0.0 3,755 2,835 4,131  
Balance sheet total (assets)  1,204 2,557 6,162 10,961 8,914  

Net Debt  -39.0 -28.6 3,647 1,630 3,914  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,268 1,949 3,266 12,175 10,192  
Gross profit growth  0.0% 53.7% 67.6% 272.8% -16.3%  
Employees  2 1 6 10 16  
Employee growth %  0.0% -50.0% 500.0% 66.7% 60.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,204 2,557 6,162 10,961 8,914  
Balance sheet change%  21.5% 112.4% 141.0% 77.9% -18.7%  
Added value  16.5 816.0 102.1 4,739.2 -628.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 500 88 3,304 456  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 -1.0 1.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  1.3% 41.9% -0.4% 38.0% -20.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  1.5% 43.4% -0.3% 54.1% -20.7%  
ROI %  2.4% 74.0% -0.4% 74.7% -28.7%  
ROE %  1.8% 57.6% 50.0% 126.8% -56.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  65.2% 55.5% 16.5% 41.4% 28.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -236.0% -3.5% 3,570.1% 32.3% -622.9%  
Gearing %  0.0% 0.0% 369.0% 62.4% 162.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.5% 2.9% 14.4%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.9 1.8 1.1 1.1 0.5  
Current Ratio  2.9 1.8 1.1 1.1 0.5  
Cash and cash equivalent  39.0 28.6 108.8 1,205.2 216.2  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  784.8 920.0 311.7 348.0 -2,787.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  8 816 17 474 -39  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  8 816 17 505 -39  
EBIT / employee  8 816 -2 462 -129  
Net earnings / employee  6 635 102 352 -125